Stocktoria

Vor Biopharma Inc. VOR

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-05

Vor Biopharma Inc. statistics & valuation

Market cap$764.6M
Return on capital-84.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-31.90% -36.70% -78.20% -120.90% 202020212022202320242025
Shares outstanding
505074 37.2M 66.0M 67.9M 6.2M 38.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-57.10% -28.40% -30.80% -59.50% -81.80% -150.00% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$2.10 -$2.33 -$1.75 -$34.03 -$70.50 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-150.0%-81.8%-59.5%-30.8%-28.4%-57.1%
Return on equity423.6%-120.9%-78.2%-36.7%-31.9%73.4%
Current ratio18.205.199.0418.0621.124.81

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.